What Somatics LLC does

Somatics LLC is a privately held medical device manufacturer founded in 1983 and headquartered in Chatham, Illinois, with a 12-person organization. The company designs, manufactures, and distributes the Thymatron System IV, an FDA-cleared Class II electroconvulsive therapy (ECT) device intended to treat catatonia and severe major depressive episodes in patients age 13 and older who are treatment-resistant or require rapid treatment response. The Thymatron incorporates proprietary algorithmic methods for stimulus delivery, seizure quality analysis, and seizure endpoint determination, and features patented safety innovations including the Independent Safety Monitor Circuit and the Audible EEG monitoring system. The device holds multiple global regulatory certifications (FDA, CE, CSA, ISO 13485:2016, TUV, IEC 60601), and Somatics is described as the leading global manufacturer of ECT equipment.

The product portfolio extends beyond the core Thymatron device to include proprietary consumables (Thymapads stimulus electrodes, Ventil-A disposable mouth protector, MouthGuard reusable oral protector), EEG/ECG/EMG monitoring electrodes, conductive gels and sprays, thermal recording paper, treatment and monitoring cables, and medical-grade carts. Companion software includes the Genie IV EEG analysis program and the thymatron-web browser application, and the company has integrated with Elektrika Inc.'s GPD software to provide HL7 EMR interfacing. Somatics also distributes educational content including The Technique of ECT video series and authoritative ECT textbooks co-produced with internationally-recognized experts.

Somatics operates a direct enterprise field sales motion in the United States complemented by a global distributor network covering more than 50 countries across North America, Europe, Asia, the Middle East, South America, Africa, and the South Pacific. Revenue is generated through hardware sales of Thymatron devices and accessories, plus recurring service contracts covering preventive maintenance throughout the device lifespan. Consumables (Thymapads and Ventil-A) provide a recurring revenue stream layered on the installed base. Pricing is not publicly disclosed and is quoted through direct sales engagement.

Name

Somatics LLC

Legal name

Somatics, LLC

Website

https://thymatron.com

Company type

Private

Founded year

1983

Operating status

Operating

Headcount range

11–50 employees

Short description

Somatics LLC is a privately held Illinois-based medical device manufacturer of the FDA-cleared Thymatron System IV electroconvulsive therapy device, serving psychiatric hospitals and treatment-resistant depression patients globally through direct US enterprise sales and a distributor network spanning 50+ countries.

Ownership category

akta.pro rank

Product category

Electroconvulsive Therapy (ECT) Medical Equipment

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Mental Wellness & Stress Management Devices (Biofeedback, Meditation/Neurostimulation Devices) (CRACAQAL)

Keywords

• Electroconvulsive therapy devices
• ECT medical equipment
• Psychiatric medical devices
• Medical device manufacturing
• Neuromodulation equipment

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales

Revenue model

1. Medical Device Sales: Sale of Thymatron System IV ECT devices and accessories including EctoBrain II testing devices, Thymapads, electrodes, conductive gels, mouth guards, and other supplies.
2. Service Contracts and Maintenance: Service contracts providing preventive maintenance and device services throughout the device lifespan with predictable costs.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Core offering

Somatics LLC manufactures and sells the Thymatron System IV, an FDA-cleared Class II medical device for electroconvulsive therapy (ECT) used to treat catatonia and severe major depressive episodes in treatment-resistant patients. The portfolio extends to companion software (thymatron-web, Genie IV), testing/training equipment (EctoBrain II), single-use consumables (Thymapads, Ventil-A, recording electrodes), reusable accessories (MouthGuard, stainless steel electrodes, carts), and ECT educational content distributed to hospitals and psychiatric facilities worldwide.

Product overview

Somatics LLC manufactures the Thymatron System IV as its core FDA-cleared ECT device, supported by companion software products including the browser-based thymatron-web application and Genie IV EEG analysis software (both for treatment data management and analysis), plus third-party compatible software GPD. The product portfolio encompasses a comprehensive range of ECT accessories including Thymapads and stainless steel stimulus electrodes, disposable and reusable mouth protectors (Ventil-A and MouthGuard), monitoring and treatment cables, conductive gels and sprays, thermal recording paper, and medical-grade carts. Somatics also distributes educational content including ECT technique videos and authoritative books on ECT practice.

Differentiator

Problem solved

Functional benefit

Brands

• Thymatron: FDA-cleared ECT device manufactured by Somatics, LLC for treatment of catatonia and severe major depressive episodes. Available as Thymatron System IV with features including ultrabrief stimulation, postictal suppression index monitoring, 4-channel EEG/ECG/EMG recording, and digital EEG machine functions.

Products and services

• Thymatron System IV FDA-cleared Class II medical device for electroconvulsive therapy (ECT) intended to treat catatonia or severe major depressive episodes associated with major depressive or bipolar disorder in patients age 13 and older who are treatment-resistant or require a rapid treatment response. Features EEG/ECG/EMG monitoring, 4-channel digital EEG machine functions, ultrabrief stimulation capability, Postictal Suppression Index, and computer-assisted seizure analysis.
• EctoBrain II (ECTO-II) Patented testing and training device that simulates patient EEG, ECG, and EMG signals to verify Thymatron and MECTA device performance and help clinicians recognize proper seizure quality. Features Patient Simulator mode for monitoring system testing and training.
• thymatron-web Browser-based application providing functionality for collecting, organizing, and reviewing treatment and monitoring data uploaded from the Thymatron ECT device. Combines real-time trace viewing, patient info management, treatment data storage, report editing, PDF generation, and EMR drop-folder support; runs on any OS with modern Chrome or Edge (MacOS, Windows 10/11, Linux).
• Genie IV (version 6.81) Computer-assisted EEG analysis software for the Thymatron System IV providing advanced EEG signal processing and analysis capabilities for ECT treatment monitoring.
• Thymapads (EPAD-C) Stimulus Electrodes Single-use adherent stimulus electrodes for bilateral or unilateral ECT that remain exactly where applied without slipping, with no exposed metal surfaces to prevent accidental shocks. Includes Signa Spray (ESPAY) bottle. Used in more than 2.5 million treatments since 1989.
• Disposable Recording Electrodes (EEDS-C) EEG/ECG/EMG adherent recording electrodes for monitoring during ECT. Small size facilitates bifrontal or fronto-mastoid application without interfering with treatment electrode placement. Packaged 5 per strip.
• Ventil-A Disposable Mouth Protector Single-use disposable mouth protector for ECT with thick 100% closed-cell foam construction and internal non-collapsible air channel allowing oxygen flow. Fits under anesthesia mask; latex-free. US Patent 6,039,046; used in more than half a million treatments since 1999.
• MouthGuard Reusable autoclavable rubber oral protector with integral airway in 2 sizes. Prevents tooth fracture or tongue bite. Lifetime warranty against cracking or crumbling. Latex-free.
• ECT Consumables and Accessories Range Catalog offering of ECT consumables and accessories including Thermal Recording Paper (EP4-C, EP4-B), Signa Gel (EGEL), Signa Spray (ESPAY), Nuprep Skin Prep Gel (NUPREP), Stainless Steel Electrodes (EECU, EEFL), Monitoring and Treatment Cables (ECEF-4, ECET-P, ELDS series, ERTH, EHAN series), Pro Cart (PROCART), and Vexio Cart (VEXIO).
• The Technique of ECT (Educational Video) 45-minute instructional video by Drs. Richard Abrams and Conrad Swartz covering modern ECT technique and practice according to APA guidelines, including patient selection, medication dosages, stimulus delivery, seizure monitoring, anesthesia techniques, and recovery management.
• Informed ECT for Patients and Families (Educational Video) Educational video by Dr. Max Fink teaching families and patients about ECT treatments and health professionals about depression categories that ECT can affect.
• Electroconvulsive Therapy (4th Edition, 2002) by Dr. Richard Abrams 4th Edition (2002) textbook by Dr. Richard Abrams covering all aspects of ECT with reviews of recent studies and a new chapter on transcranial magnetic stimulation; described as the gold standard for ECT literature analysis.
• Electroconvulsive and Neuromodulation Therapies by Dr. Conrad M. Swartz Groundbreaking text edited by Dr. Conrad M. Swartz covering the scientific basis and clinical practice of ECT plus the latest nonconvulsive electrical and magnetic brain stimulation therapies. Over 600 pages with 50+ contributing authors.

Quantifiable outcome

• Thymapads used in more than 2.5 million treatments since 1989
• +1 more outcomes

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability2 records

Feature11 records

Partnerships

Four partnerships are on record, tiered core and minor.

• Elektrika Inc.coreTechnology or IntegrationElektrika Inc. developed GPD (General Purpose Device) software, a Windows program that works with Thymatron ECT devices providing modern workflow including real-time trace monitoring, patient database, EMR interfacing via HL7, analysis of parameters over time, and data export capabilities. GPD is free for use with the Thymatron and has flexible HL7 configuration.
• Dr. Max FinkminorOthersInternationally-recognized ECT expert who co-produced educational video series with Somatics: Informed ECT for Patients and Families. Dr. Fink authored related educational materials.
• Dr. Richard AbramsminorOthersInternationally-renowned ECT expert who co-produced The Technique of ECT video series with Somatics and authored the book Electroconvulsive Therapy (4th Edition, 2002) distributed exclusively by Somatics.
• Dr. Conrad SwartzminorOthersInternationally-recognized ECT expert who co-produced The Technique of ECT video series with Somatics and authored the ECT Dosing by the Benchmark Method paper and the book Electroconvulsive and Neuromodulation Therapies.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Brainsway: Brainsway develops Deep TMS systems FDA-cleared for treatment-resistant depression and other psychiatric indications, positioning it as a direct emerging competitor to ECT in the psychiatric neuromodulation market.
• LivaNova (formerly Cyberonics): LivaNova markets Vagus Nerve Stimulation (VNS) Therapy, an implanted neurostimulation device FDA-cleared for treatment-resistant depression, representing another neuromodulation alternative that competes for the same severe psychiatric patient population served by ECT.
• Neuronetics: Neuronetics manufactures NeuroStar TMS, a transcranial magnetic stimulation system for treatment-resistant depression — the principal non-convulsive neuromodulation alternative that competes with ECT for the same psychiatric patient population and provider budget.
• Magstim: Magstim is a long-established manufacturer of transcranial magnetic stimulation devices used clinically for depression and psychiatric research, representing the leading non-invasive alternative modality to ECT for treatment-resistant depression.
• MECTA Corporation: MECTA is the other major global manufacturer of ECT devices and is explicitly referenced in Somatics' own materials (the EctoBrain II testing device is designed to work with both Thymatron and MECTA systems), making it the closest direct competitor in the clinical ECT equipment market.

Broad incumbents

• Nihon Kohden: Nihon Kohden is a major global manufacturer of EEG, EMG, and neurodiagnostic monitoring equipment used alongside ECT, overlapping with Somatics in the EEG-based seizure-quality measurement features of the Thymatron System IV.
• Medtronic: Medtronic is one of the largest medical device companies globally, offering deep brain stimulation and other neuromodulation platforms relevant to psychiatric care, representing a broad incumbent competitor in the broader neurostimulation market where ECT sits.
• Abbott (formerly St. Jude Medical): Abbott manufactures deep brain stimulation (DBS) systems and a broad portfolio of neuromodulation devices used in psychiatry and neurology, making it a broader incumbent in the implanted neurostimulation space where ECT competes for severe depression patients.

Others

• Elektrika Inc. Elektrika developed the GPD (General Purpose Device) software that interfaces with the Thymatron for real-time trace monitoring, patient databases, and HL7 EMR integration — a core technology and integration partner in Somatics' software ecosystem.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/somatics-llc

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Somatics LLC